Effectiveness of the first component of Gam-COVID-Vac (Sputnik V) on reduction of SARS-CoV-2 confirmed infections, hospitalisations and mortality in patients aged 60-79: a retrospective cohort study in Argentina

BACKGROUND: A first-dose of various vaccines provides acceptable protection against infections by SARS-CoV-2 and evolution to the most severe forms of COVID-19. The recombinant adenovirus (rAd)-based vaccine, Gam-COVID-Vac (Sputnik V), was proven efficacious but information about effectiveness in th...

Descripción completa

Detalles Bibliográficos
Autores principales: González, Soledad, Olszevicki, Santiago, Salazar, Martín, Calabria, Ana, Regairaz, Lorena, Marín, Lupe, Campos, Patricia, Varela, Teresa, Martínez, Veronica V. González, Ceriani, Leticia, Garcia, Enio, Kreplak, Nicolás, Pifano, Marina, Estenssoro, Elisa, Marsico, Franco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435263/
https://www.ncbi.nlm.nih.gov/pubmed/34541480
http://dx.doi.org/10.1016/j.eclinm.2021.101126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8435263/
https://www.ncbi.nlm.nih.gov/pubmed/34541480
http://dx.doi.org/10.1016/j.eclinm.2021.101126

Ejemplares similares